Advocating for Change
April 22, 2016
By Amanda Plakosh
It’s 5:47 pm on Friday night. After a long week at work, you excitedly drive towards the elementary school to pick up your soon to be 7-year old son. His birthday is on Saturday and you have an unforgettable party planned. The grandparents are coming in from out of town and his best buddies from school will be coming over first thing in the morning for a backyard bash.
The College of Pharmacy Monthly Research Publication Highlight details a novel mechanism by which changes in the blood-brain barrier may contribute to the development of Alzheimer’s disease
April 08, 2016
By Greg Graf
The University of Kentucky (UK) College of Pharmacy Research Publication Highlight for March 2016 is titled “Aβ40 Reduces P-glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway” and was published in The Journal of Neuroscience.
College of Pharmacy Alumni Honored
April 01, 2016
Throughout its history, the University of Kentucky College of Pharmacy has produced outstanding pharmacy practitioners and researchers that have changed the way we think about preventative care and disease treatment, and have ultimately improved our health and the health of our loved ones.
The College of Pharmacy Monthly Research Publication Highlight details the synthesis of novel antimicrobial compounds that may be useful in treating antibiotic-resistant infections.
March 03, 2016
The UK College of Pharmacy Research Publication Highlight for February, 2016 is titled “Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles” and was published in the Journal of Medicinal Chemistry.
Monthly Research Publication highlights the use of low cost generic drug program usage and trends
February 25, 2016
The UK College of Pharmacy Research Publication Highlight for January 2016 is titled “The Prevalence and Predictors of Low-Cost Generic Program Use in the Pediatric Population” and was published in Drugs – Real World Outcomes.
The study was conducted in the UK College of Pharmacy’s Institute for Pharmaceutical Outcomes and Policy (IPOP). Graduate students Nathan Pauly and Joshua Brown led the effort under the supervision of IPOP Director, Dr. Jeff Talbert, PhD.
Is the Next Blockbuster Drug in Kentucky's Coal Mines?
January 21, 2016
In their ongoing quest to develop the latest and most effective drugs for disease treatment, researchers in the University of Kentucky's Center for Pharmaceutical Research and Innovation (CPRI) are looking deep — as in, deep underground.
Anticancer Natural Products Article is Publication Highlight of the Year
December 07, 2015
A collaborative research project that will help provide investigators a greater understanding of anticancer properties of natural products is the UK College of Pharmacy Publication Highlight of the Year for 2015.
Graduate Student Excellent Recognized at Symposium
November 25, 2015
The College hosted its annual Symposium on Drug Discovery and Development November 19 and several graduate students were recognized for their excellence as part of this year’s event. The Symposium featured a poster session and an elevator speech competition for graduate students.
The following students were honored for their contributions.
First Place: Ashley Lay (Dr. Eric Munson’s lab)
Second Place: Meredith Saunders (Behavioral Neuroscience and Psychopharmacology)
Third Place: Daniel Binzel (Dr. Peixuan Guo’s lab)
Monthly Publication Highlights the Development of New Drug Carriers
November 20, 2015
The UK College of Pharmacy Research Publication Highlight for November 2015 is titled “Polymer Nanoassemblies with Solvato- and Halo-Fluorochromism for Drug Release Monitoring and Metastasis Imaging” and was published in Therapeutic Delivery.
UK Awarded $6 Million to Further Develop Treatment for Cocaine Abuse
November 20, 2015
University of Kentucky College of Pharmacy Professor Chang-Guo Zhan, teamed with fellow UK faculty members Fang Zheng and Sharon Walsh, and Professor Mei-Chuan Ko from Wake Forest University, recently received $6 million in funding over five years to further develop a potential treatment for cocaine abuse.
The project is funded via the National Institute on Drug Abuse Translational Avant-Garde Award and will help push a promising new therapy for overdose and addiction closer to clinical trials.